Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/7754 stock hub

TPEX/7754 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/7754is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.7B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/7754

In the news

Latest news · TPEX/7754

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/En/a

P25 14.4P50 18P75 31.9

ROE-72.9

P25 -16.2P50 0.3P75 9.8

ROIC-42.5

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/7754 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

158

Groups with data

Currency

TWD

Showing 158 of 158 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Enterprise value	TWD 5.4B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Isin	TW0007754004
Last refreshed	2026-05-10
Market cap	TWD 5.7B
Price	TWD 60.6
Price currency	TWD
Sector	Healthcare
Sic	2834
Symbol	tpex/7754
Website	https://www.ajpharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.28%
EV Earnings	-15.09x
EV/FCF	-15.29x
FCF yield	-6.2%
P/B ratio	17.82x
P/S ratio	754.8x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	16.64%
Gross Profit	TWD 1.3M
Gross Profit Growth	168.59%
Gross Profit Growth3 Y	-61.17%
Gross Profit Growth5 Y	5.19%
Net Income	TWD -357.9M
Net Income Growth Years	0%
Pretax Margin	-4,738.73%
ROA	-29
ROCE	-75.79
ROE	-72.89
ROIC	-42.49

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	152.56%
EPS Growth Years	2
Revenue Growth	-92.17x
Revenue Growth Q	-97.49x
Revenue Growth Years	0x
Revenue Growth3 Y	-65.38x
Revenue Growth5 Y	39.39x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.01
Assets	TWD 590.1M
Cash	TWD 348.5M
Current Assets	TWD 369.8M
Current Liabilities	TWD 102.8M
Debt	TWD 49.4M
Debt Equity	TWD 0.15
Debt FCF	TWD -0.14
Equity	TWD 319.8M
Interest Coverage	-230.7
Liabilities	TWD 270.3M
Long Term Assets	TWD 220.3M
Long Term Liabilities	TWD 167.5M
Net Cash	TWD 299.1M
Net Cash By Market Cap	TWD 5.25
Net Cash Growth	-54.03%
Net Debt Equity	TWD -0.94
Tangible Book Value	TWD 252.9M
Tangible Book Value Per Share	TWD 2.69

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.6
Inventory Turnover	0.28
Net Working Capital	TWD -75.2M
Quick ratio	3.4
Working Capital	TWD 267M
Working Capital Turnover	TWD 0.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.06%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	152.4%
200-day SMA	49.16
50-day SMA	61.85
50-day SMA vs 200-day SMA	50over200
All Time High	72.4
All Time High Change	-16.3%
All Time High Date	2024-06-25
All Time Low	14.05
All Time Low Change	331.32%
All Time Low Date	2025-04-09
ATR	2.17
Beta1y	-0.07
Beta2y	0.56
Ch YTD	18.36
High	61.2
High52	69.9
High52 Date	2026-04-08
High52ch	-13.3%
Low	59.6
Low52	22.15
Low52 Date	2025-07-01
Low52ch	173.59%
Ma50ch	-2.02%
Price vs 200-day SMA	23.27%
RSI	43.44
RSI Monthly	64.64
RSI Weekly	64.52
Sharpe ratio	2.41x
Sortino ratio	6.07
Total Return	-1.06%
Tr YTD	19.3
Tr1m	-9.55%
Tr1w	-0.98%
Tr3m	22.16%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -369.4M
Operating margin	-4,891

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	50,241,177%
Net Borrowing	-5,977,000
Shares Insiders	2.57%
Shares Institutions	12.45%
Shares Out	94,064,039
Shares Qo Q	0.23%
Shares Yo Y	1.06%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -361.3M
Average Volume	287,698.6x
Bv Per Share	3.4
CAPEX	TWD -2.9M
Ch1m	-9.55
Ch1w	-0.98
Ch1y	150.4
Ch3m	21.2
Ch6m	33.19
Change	-0.98%
Change From Open	-0.16
Close	61.2
Days Gap	-0.82
Depreciation Amortization	37,510,000
Dollar Volume	20,021,512.8
Earnings Date	2026-08-12
EBIT	TWD -369.4M
EBITDA	TWD -331.9M
EPS	TWD -3.81
F Score	2
FCF	TWD -353.2M
FCF EV Yield	-6.54x
FCF Per Share	TWD -3.75
Financing CF	-2,522,000
Fiscal Year End	December
Founded	2,014
Investing CF	70,234,000
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2025-12-31
Ma150	52.45
Ma150ch	15.54%
Ma20	62.23
Ma20ch	-2.62%
Net CF	-282,573,000
Next Earnings Date	2026-08-12
Open	60.7
Position In Range	62.5
Ppne	68,104,000
Price Date	2026-05-08
Ptbv Ratio	22.54
Relative Volume	1.26x
Revenue	7,552,000x
SBC By Revenue	106.99x
Share Based Comp	8,080,000
Tr6m	34.24%
Volume	330,388
Z Score	1.75

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/7754 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/7754 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/7754?

Insider, institutional, and short-interest positioning.

Institutional ownership

+12.5%

Share of float held by funds and institutions

Insider ownership

+2.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.1%

Negative means the company is buying back shares.

Technical

TPEX/7754 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.4

Neutral momentum band

Price vs 200-day MA

+23.3%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

2.41

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/7754

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/7754 stock rating?

tpex/7754 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/7754 analysis?

The full report lives at /stocks/tpex/7754/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/7754?

The latest report frames tpex/7754 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/7754 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.